Back to Search Start Over

Segmentation of glioblastomas via 3D FusionNet.

Authors :
Guo, Xiangyu
Zhang, Botao
Peng, Yue
Chen, Feng
Li, Wenbin
Source :
Frontiers in Oncology; 2024, p1-10, 10p
Publication Year :
2024

Abstract

Introduction: This study presented an end-to-end 3D deep learning model for the automatic segmentation of brain tumors. Methods: The MRI data used in this study were obtained from a cohort of 630 GBM patients from the University of Pennsylvania Health System (UPENN-GBM). Data augmentation techniques such as flip and rotations were employed to further increase the sample size of the training set. The segmentation performance of models was evaluated by recall, precision, dice score, Lesion False Positive Rate (LFPR), Average Volume Difference (AVD) and Average Symmetric Surface Distance (ASSD). Results: When applying FLAIR, T1, ceT1, and T2 MRI modalities, FusionNet-A and FusionNet-C the best-performing model overall, with FusionNet-A particularly excelling in the enhancing tumor areas, while FusionNet-C demonstrates strong performance in the necrotic core and peritumoral edema regions. FusionNet-A excels in the enhancing tumor areas across all metrics (0.75 for recall, 0.83 for precision and 0.74 for dice scores) and also performs well in the peritumoral edema regions (0.77 for recall, 0.77 for precision and 0.75 for dice scores). Combinations including FLAIR and ceT1 tend to have better segmentation performance, especially for necrotic core regions. Using only FLAIR achieves a recall of 0.73 for peritumoral edema regions. Visualization results also indicate that our model generally achieves segmentation results similar to the ground truth. Discussion: FusionNet combines the benefits of U-Net and SegNet, outperforming the tumor segmentation performance of both. Although our model effectively segments brain tumors with competitive accuracy, we plan to extend the framework to achieve even better segmentation performance. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2234943X
Database :
Complementary Index
Journal :
Frontiers in Oncology
Publication Type :
Academic Journal
Accession number :
181229079
Full Text :
https://doi.org/10.3389/fonc.2024.1488616